PMA P840019

Device
TANDEM(R) E CEA IMMUNORADIOMETRIC ASSAY
Applicant
Hybritech, Inc.
PMA number
P840019
Supplement
S012
Product code
DHX
Decision date
1996-03-07
Generic name
SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN
Approval order statement
MODIFICATIONS TO THE HYBRITECH TANDEM-E CEA ASSAY WHITH ENHANCEMENTS IN THE FORMUALTION OF THE ALKALINE PHOSPHATASE-LABELED ANTI-CEA ANTIBODY CONJUGATE AND THE ADDTION OF THE BLOCKING REAGENT POLY MAK 33, A COPOLYMER OF INTACT AND FAB FRAGMENTED MOUSE ANTI-HUMAN CK-MM ANTIBODIES

Current openFDA PMA Record#

Device
TANDEM(R) E CEA IMMUNORADIOMETRIC ASSAY
Applicant
Hybritech, Inc.
PMA number
P840019
Supplement
S012
Product code
DHX
Generic name
SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN
Decision date
1996-03-07
Decision code
APPR
Date received
1995-09-21
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
MODIFICATIONS TO THE HYBRITECH TANDEM-E CEA ASSAY WHITH ENHANCEMENTS IN THE FORMUALTION OF THE ALKALINE PHOSPHATASE-LABELED ANTI-CEA ANTIBODY CONJUGATE AND THE ADDTION OF THE BLOCKING REAGENT POLY MAK 33, A COPOLYMER OF INTACT AND FAB FRAGMENTED MOUSE ANTI-HUMAN CK-MM ANTIBODIES